Followers | 4054 |
Posts | 152159 |
Boards Moderated | 3 |
Alias Born | 08/05/2009 |
Friday, June 16, 2017 8:19:47 AM
Published: June 16, 2017 7:04 a.m. ET
By
TOMI
KILGORE
REPORTER AND EDITOR
Shares of Celsion Corp. CLSN, +97.07% rocketed 42% in premarket trade Friday, after the cancer drug development company filed to withdraw plans for a stock offering. The company had originally filed on April 5 an S-1 statement with the Securities and Exchange Commission for the sale of shares, which was amended as recently as Wednesday for the sale of 2.45 million common shares and pre-funded and base warrants to buy over 4 million shares. In Friday's filing, the company stated that it submitted the withdrawal "because it does not intend to pursue the contemplated offering at this time." Earlier this week, the company said it had regained the minimum-bid compliance for the continued listing of its stock on the Nasdaq. That followed a 1-for-14 reverse stock split on May 30. The stock has plunged 52% year to date through Thursday, while the iShares Nasdaq Biotechnology ETF IBB, -0.77% has climbed 11% and the S&P 500 SPX, -0.22% has gained 8.7%.
VHAI - Vocodia Partners with Leading Political Super PACs to Revolutionize Fundraising Efforts • VHAI • Sep 19, 2024 11:48 AM
Dear Cashmere Group Holding Co. AKA Swifty Global Signs Binding Letter of Intent to be Acquired by Signing Day Sports • DRCR • Sep 19, 2024 10:26 AM
HealthLynked Launches Virtual Urgent Care Through Partnership with Lyric Health. • HLYK • Sep 19, 2024 8:00 AM
Element79 Gold Corp. Appoints Kevin Arias as Advisor to the Board of Directors, Strengthening Strategic Leadership • ELMGF • Sep 18, 2024 10:29 AM
Mawson Finland Limited Further Expands the Known Mineralized Zones at Rajapalot: Palokas step-out drills 7 metres @ 9.1 g/t gold & 706 ppm cobalt • MFL • Sep 17, 2024 9:02 AM
PickleJar Announces Integration With OptCulture to Deliver Holistic Fan Experiences at Venue Point of Sale • PKLE • Sep 17, 2024 8:00 AM